Loading...

Skip to main content
Call us at +1-800-604-9114 for more information about our products or contact us online Need help? +1-800-604-9114 or contact us
product-image-AAA213710_IF13.jpg IF (Immunofluorescence) (Shifting (Mitigation of) Daratumumab in Myeloma plasma using modified anti-Daratumumab idiotype antibody in a serum immunofixation assay. Samples: All lanes contain Human IgG-Kappa plasma samples. Lanes 1-4 contain the one patient sample, Lanes 5-8 contain a different patient sample. Lanes 1 & 5 contain only the patient sample, Lanes 3, 4, 7 & 8 contain patient samples + daratumumab, and Lanes 4 & 8 also contain modified Anti-Daratumuab (AAA213710-modified). Row A samples were reacted with anti-human IgG antisera, Row B samples were reacted with anti-human Kappa light chain. Lane 2 & 6 are serum protein electrophoresis of the patient samples without daratumumab.)

Goat Daratumumab Idiotypic Polyclonal Antibody

Goat anti-Daratumumab Idiotypic Antibody, Affinity Purified

Applications
Immunofluorescence, ELISA
Purity
Antigen Affinity Purified
Synonyms
Daratumumab Idiotypic, Antibody; Goat anti-Daratumumab Idiotypic Antibody, Affinity Purified; Daratumumab; anti-Daratumumab Idiotypic antibody
Ordering
Host
Goat
Clonality
Polyclonal
Purity/Purification
Antigen Affinity Purified
Form/Format
Liquid. Whole IgG. Phosphate Buffered Saline (PBS) containing 0.09% Sodium Azide
Concentration
1000ug/ml (varies by lot)
Applicable Applications for anti-Daratumumab Idiotypic antibody
IFE (ImmunofixationElectrophoresis), ELISA
Conjugation
Unconjugated
Preparation and Storage
Store at 2-8 degree C
Shelf Life: 2 years from date of receipt

IF (Immunofluorescence)

(Shifting (Mitigation of) Daratumumab in Myeloma plasma using modified anti-Daratumumab idiotype antibody in a serum immunofixation assay. Samples: All lanes contain Human IgG-Kappa plasma samples. Lanes 1-4 contain the one patient sample, Lanes 5-8 contain a different patient sample. Lanes 1 & 5 contain only the patient sample, Lanes 3, 4, 7 & 8 contain patient samples + daratumumab, and Lanes 4 & 8 also contain modified Anti-Daratumuab (AAA213710-modified). Row A samples were reacted with anti-human IgG antisera, Row B samples were reacted with anti-human Kappa light chain. Lane 2 & 6 are serum protein electrophoresis of the patient samples without daratumumab.)

product-image-AAA213710_IF13.jpg IF (Immunofluorescence) (Shifting (Mitigation of) Daratumumab in Myeloma plasma using modified anti-Daratumumab idiotype antibody in a serum immunofixation assay. Samples: All lanes contain Human IgG-Kappa plasma samples. Lanes 1-4 contain the one patient sample, Lanes 5-8 contain a different patient sample. Lanes 1 & 5 contain only the patient sample, Lanes 3, 4, 7 & 8 contain patient samples + daratumumab, and Lanes 4 & 8 also contain modified Anti-Daratumuab (AAA213710-modified). Row A samples were reacted with anti-human IgG antisera, Row B samples were reacted with anti-human Kappa light chain. Lane 2 & 6 are serum protein electrophoresis of the patient samples without daratumumab.)

ELISA

(Inhibition of Daratumumab-HRP binding to Recombinant CD38 by ELISA. Samples: Solid phase immobilized recombinant CD38 incubated with HRP conjugated Daratumumab (0.5 ug/ml) in the presence increasing concentrations of Goat anti-Daratumumab idiotypic antibody (AAA213710).)

product-image-AAA213710_ELISA15.jpg ELISA (Inhibition of Daratumumab-HRP binding to Recombinant CD38 by ELISA. Samples: Solid phase immobilized recombinant CD38 incubated with HRP conjugated Daratumumab (0.5 ug/ml) in the presence increasing concentrations of Goat anti-Daratumumab idiotypic antibody (AAA213710).)
Related Product Information for anti-Daratumumab Idiotypic antibody
Daratumumab is a human monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of multiple myeloma. Daratumumab binds to CD38 on multiple myeloma cells and induces cell death through a number of different mechanisms including antibody-dependent cellular cytotoxicity.
Product Categories/Family for anti-Daratumumab Idiotypic antibody

Similar Products

Product Notes

The Daratumumab Idiotypic (Catalog #AAA213710) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's Daratumumab Idiotypic can be used in a range of immunoassay formats including, but not limited to, IFE (ImmunofixationElectrophoresis), ELISA. Researchers should empirically determine the suitability of the Daratumumab Idiotypic for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "Daratumumab Idiotypic, Polyclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Item has been added to Shopping Cart

If you are ready to order, navigate to Shopping Cart and get ready to checkout.

Submit a Question

Please complete the form below and a representative will contact you as soon as possible.

Request more Information

Please complete the form below and a representative will contact you as soon as possible.

Request a Manual

Please complete the form below and a representative will contact you as soon as possible.

Request a Quote

Please complete the form below and a representative will contact you as soon as possible.